Natural Capsules Ltd Releases FY26 Annual Report
Natural Capsules Ltd has released its Annual Report for the Financial Year 2025-26, highlighting a strategic shift towards innovation-driven growth. The company has expanded its operations beyond capsule manufacturing into complex steroidal active pharmaceutical ingredients (APIs), with its Tumkur API facility commencing commercial production and a new HPMC line commissioned. Despite facing challenges including a temporary facility disruption and a reported loss during the year, the company aims to leverage its investments in R&D and technology for sustained growth. The report also details the upcoming 33rd Annual General Meeting (AGM) scheduled for August 12, 2026, to be held via Video Conference, with August 5, 2026, set as the cut-off date for voting eligibility.
Key Highlights
- FY26 Annual Report released, focusing on innovation-driven growth.
- Expanded into steroidal API production with commercial launch.
- Faced operational challenges and a reported loss in FY26.
- 33rd AGM scheduled for August 12, 2026, via Video Conference.
- Company aims to convert innovation into sustained growth.
Price Impact
More from NATCAPSUQ